Abstract
Perforated synapses, which contain a discontinuous density along the postsynaptic membrane, can increase or decrease in numbers following various behavioral and biochemical manipulations. We have previously established that 14-day treatment with haloperidol causes an increase in the number of perforated synapses within the caudate nucleus (dorsolateral region) but not the nucleus accumbens (Meshul and Casey 1989). This effect was reversed if the animals were withdrawn from the drug for an equivalent period of time. We have now further examined the effects of haloperidol administration, which is associated with a high incidence of extrapyramidal side effects (EPS) and tardive dyskinesia (TD), and assessed the effects of clozapine, which appears to have a lower potential for inducing EPS and TD. Administration of haloperidol for 2 weeks significantly increased the percentage of perforated synapses in the caudate, but not in the nucleus accumbens or layer VI of medial prefrontal cortex (MPCx). There was an increase in specific [125I]epidepride binding to D-2 receptors in the caudate nucleus and MPCx following haloperidol. Administration of clozapine for 2 weeks did not affect the percentage of perforated synapses in any of the three dopamine (DA)-rich regions that were examined. There was an increase in specific [3H]SCH 23390 binding to D-1 receptors and in specific [125I]epidepride binding to D-2 receptors only within MPCx following clozapine. The absence of any change in the density of perforated synapses within the dorsolateral caudate nucleus following clozapine correlates with: 1) the lack of effect on specific DA receptor binding or down regulation of serotonin (5-HT2) receptors (as reported by others), or 2) the inability in clozapine-treated animals to depolarize block substantia nigra (A9) DA neurons. These results may be related to the low incidence of EPS and TD observed with clozapine.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Andersen PH, Gronvald FC, Jansen JA (1985) A comparison between dopamine-stimulated adenylate cyclase and3H-SCH 23390 binding in rat striatum. Life Sci 37:1971–1983
Andersen PH, Braestrup C (1986) Evidence for different states of the dopamine D1 receptor: clozapine and fluperlapine may preferentially label an adenylate cyclase-coupled state of the D1 receptor. J Neurochem 47:1822–1831
Baldessarini RJ, Tarsy D (1980) Pathophysiologic basis of tardive dyskinesia. Adv Biochem Psychopharmacol 24:451–455
Bartholini G, Haefely W, Jalfre M, Keller HH, Pletscher A (1972) Effects of clozapine on central catecholaminergic neurone systems. Br J Pharmacol 46:736
Beckstead RM, Domesick VB, Nauta WJH (1979) Efferent connections of the substantia nigra and ventral tegmental area in the rat. Brain Res 175:191–217
Benes FM, Paskevich PA, Domesick VB (1983) Haloperidol induced plasticity of axon terminals in rat substantia nigra. Science 221:969–971
Benes FM, Paskevich PA, Davidson J, Domesick VB (1985a) The effects of haloperidol on synaptic patterns in the rat striatum. Brain Res 329:265–274
Benes FM, Paskevich PA, Davidson J, Domesick VB (1985b) Synaptic rearrangements in medial prefrontal cortex of haloperidoltreated rats. Brain Res 348:15–20
Berendse HW, Groenewegen HJ (1990) Organization of the thalamostriatal projections in the rat, with special emphasis on the ventral striatum. J Comp Neurol 299:187–228
Bersani G, Grispini A, Marini S, Pasini A, Valducci M, Ciani N (1986) Neuroleptic-induced extrapyramidal side effects: clinical perspectives with ritanserin (R 55667), a new selective 5-HT2 receptor blocking agent. Curr Ther Res 40:492–499
Bersani G, Grispini A, Marini S, Pasini A, Valducci M, Ciani N (1990) 5-HT2 antagonist ritanserin in neuroleptic-induced parkinsonism: a double-blind comparison with orphenadrine and placebo. Clin Neuropharmacol 13:500–506
Bunney BS, Grace AA (1978) Acute and chronic haloperidol treatment: comparison of effects of nigral dopaminergic cell activity. Life Sci 23:1715–1728
Burki HR, Ruch W, Asper H, Baggiolini M, Stille G (1974) Effect of single and repeated administration of clozapine on the metabolism of dopamine and noradrenaline in the brain of the rat. Eur J Pharmacol 27:180–190
Carvey PM, Braun AR, Kao L-C, Klawans HL (1987) Effects of dopamine antagonists and apomorphine on regional energy metabolism in rat CNS. Clin Neuropharmacol 10:247–260
Casey DE (1987) Tardive dyskinesia. In: Meltzer HY (ed) Psychopharmacology: the third generation of progress. Raven Press, New York, pp 1411–1419
Casey DE (1989a) Clozapine: neuroleptic-induced EPS and tardive dyskinesia. Psychopharmacology 99:S47–53
Casey DE (1989b) Serotonergic aspects of acute extrapyramidal syndromes in nonhuman primates. Psychopharmacol Bull 25:457–459
Chiodo LA, Bunney BS (1983) Typical and atypical neuroleptics: differential effects of chronic administration on the activity of A9 and A10 midbrain dopaminergic neurons. J Neurosci 3:1607–1619
Chiodo LA, Bunney BS (1985) Possible mechanisms by which repeated clozapine administration differentially affects the activity of two subpopulations of midbrain dopamine neurons. J Neurosci 5:2539–2544
Costall B, Naylor RJ (1976) A comparison of the abilities of typical neuroleptic agents and of thioridazine, clozapine, sulpiride and metoclopramide to antagonize the hyperactivity induced by dopamine applied intracerebrally to areas of the extrapyramidal and mesolimbic systems systems. Eur J Pharmacol 40:9–18
Duncan GE, Creswell HE, McCown JJ, Paul IA, Mueller RA, Breese GR (1987) Behavioral and neurochemical responses to haloperidol and SCH-23390 in rats treated neonatally or as adults with 6-hydroxydopamine. J Pharmacol Exp Ther 243:1027–1034
Dunnett SD, Iversen SD (1982) Sensorimotor impairments following localized kainic acid and 6-hydroxydopamine lesions of the striatum. Brain Res 248:121–127
Einot I, Gabriel KR (1975) A study of the powers of several members of multiple comparisons. J Am Statist Assoc 70:574–583
Emson PC, Koob GF (1978) The origin and distribution of dopamine-containing afferents to the rat frontal cortex. Brain Res 142:249–267
Gallager DW, Aghajanian GK (1976) Effect of antipsychotic drugs on firing of dorsal raphe cells. Eur J Pharmacol 39:341–363
Geinisman Y, de Toledo-Morrell L, Morrell F (1986) Loss of perforated synapses in the dentate gyrus: morphological substrate of memory deficit in aged rats. Proc Natl Acad Sci USA 83:3027–3031
Greenough WT, West RW, DeVoogd TJ (1978) Subsynaptic plate perforations: changes with age and experience in the rat. Science 202:1096–1098
Hatton JD, Ellisman MH (1982) A restructuring of hypothalamic synapses is associated with motherhood. J Neurosci 2:704–707
Hyttel J, Larsen J-J, Christensen AV, Arnt, J (1985) Receptor binding profiles of neuroleptics. Psychopharmacology 96[Suppl]:9–18
Kebabian JW, Calne DB (1979) Multiple receptors for dopamine. Nature 277:93–96
Kelley AE, Domesick VB, Nauta WJH (1982a) The amygdalostriatal projection in the rat-an anatomical study by anterograde and retrograde tracing methods. Neuroscience 7:615–630
Kelley AE, Domesick VB (1982b) The distribution of the projections from the hippocampal formation to the nucleus accumbens: an anterograde- and retrograde-horseradish peroxidase study. Neuroscience 7:2321–2335
Kostowski W, Gumulka W, Czlonkowski A (1972) Reduced cataleptogenic effects of some neuroleptics in rats with lesioned midbrain raphe and treated with p-chlorophenylalanine. Brain Res 48:443–446
Lindvall O, Bjorklund A, Divac I (1978) Organization of catecholamine neurons projecting to the frontal cortex in the rat. Brain Res 142:1–24
McGeorge AJ, Faull RLM (1989) The organization of the projection from the cerebral cortex to the striatum in the rat. Neuroscience 29:503–537
McMillen BA, Shore PA (1978) Comparative effects of clozapine and alpha-adrenoreceptor blocking drugs on regional noradrenaline metabolism in rat brain. Eur J Pharmacol 52:225–230
Meltzer HY, Matsubara S, Lee J-C (1989) Classification of typical and atypical antipsychotic drugs on the basis of dopamine D-1, D-2 and serotonin2 pKi values. J Pharmacol Exp Ther 251:238–246
Meshul CK, Casey DE (1989) Regional, reversible ultrastructural changes in rat brain with chronic neuroleptic treatment. Brain Res 489:338–346
Meshul CK, Janowsky A, Casey DE, Stallbaumer PK (1990) Haloperidol-induced synaptic changes in rat caudate nucleus are prevented by prior treatment with MK-801 or lesioning of the thalamus. Soc Neurosci Abstr 16:419
Miller RJ, Hiley CR (1974) Anti-muscarinic properties of neuroleptics and drug-induced parkinsonism. Nature 248:596–597
Neve KA, Henningsen A, Kinzie JM, de Paulis T, Schmidt DE, Kessler RM, Janowsky A (1990) Sodium-dependent isomerization of dopamine D-2 receptors characterized using [125I]epidepride, a high affinity substituted benzamide ligand. J Pharmacol Exp Ther 252:1108–1116
Nieto-Sampedro M, Hoff SF, Cotman CW (1982) Perforated post-synaptic densities: probable intermediates in synapse turnover. Proc Natl Acad Sci USA 79:5718–5722
O'Dell SJ, LaHoste GJ, Widmark CB, Shapiro RM, Potkin SG, Marshall JF (1990) Chronic treatment with clozapine or haloperidol differentially regulates dopamine and serotonin receptors in rat brain. Synapse 6:146–153
Paxinos G, Watson C (1986) The rat brain in stereotaxic coordinates, 2nd edn. Academic Press, San Diego
Peroutka SJ, Snyder SH (1980) Relationships of neuroleptic drug effects at brain dopamine, serotonin, alpha-adrenergic, and histamine receptors to clinical potency. Am J Psychiatry 137:1518–1522
Phelps PE, Houser CR, Vaughn JE (1985) Immunocytochemical localization of choline acetyltransferase within the rat neostriatum: a correlated light and electron microscopic study of cholinergic neurons and synapses. J Comp Neurol 238:286–307
Pickel VM (1986) Ultrastructure of central catecholaminergic neurons. In: Panula P, Paivarinta H, Soinila S (eds) Neurohistochemistry: modern methods and applications. Liss, New York, pp 397–423.
Ribak CE, Vaughn JE, Barber RP (1981) Immunocytochemical localization of GABAergic neurones at the electron microscopical level. Histochem J 13:555–582
Seeman P, Grigoriadis D (1987) Dopamine receptors in brain and periphery. Neurochem Int 10:1–25
Sesack SR, Deutch AY, Roth RH, Bunney BS (1989) Topographical organization of the efferent projections of the medial prefrontal cortex in the rat: an anterograde tract-tracing study withPhaseolus vulgaris leucoagglutinin. J Comp Neurol 290:213–242
Snyder SH, Banerjee SP, Yamamura HI, Greenberg D (1974) Drugs, neurotransmitters, and schizophrenia. Science 184:1243–1253
Steinbusch HWM (1981) Distribution of serotonin-immunoreactivity in the central nervous system of the rat — cell bodies and terminals. Neuroscience 6:557–618
Stevens JR (1973) An anatomy of schizophrenia? Arch Gen Psychiatry 29:177–189
Ugedo L, Grenhoff J, Svensson TH (1989) Ritanserin, a 5-HT2 receptor antagonist, activates midbrain dopamine neurons by blocking serotonergic inhibition. Psychopharmacology 98:45–50
Van Eden CG, Hoorneman EMD, Buijs RM, Matthijssen MAH, Geffard M, Uylings HBM (1987) Immunocytochemical localization of dopamine in the prefrontal cortex of the rat at the light and electron microscopical level. Neuroscience 22:849–862
Vincent SR, McSparren J, Wang RY, Benes FM (1989) Effect of chronic administration of neuroleptics on synapses of layer VI medial prefrontal cortex. Soc Neurosci Abstr 15:269
Vrensen G, Cardozo JN (1981) Changes in size and shape of synaptic connections after visual training: an ultrastructural approach of synaptic plasticity. Brain Res 218:79–97
White FJ, Wang RY (1983) Comparison of the effects of chronic haloperidol treatment on A9 and A10 dopamine neurons in the rat. Life Sci 32:983–993
Wilmot CA, Szczepanik AM (1989) Effects of acute and chronic treatments with clozapine and haloperidol on serotonin (5-HT2) and dopamine (D2) receptors in the rat brain. Brain Res 487:288–298
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Meshul, C.K., Janowsky, A., Casey, D.E. et al. Effect of haloperidol and clozapine on the density of “perforated” synapses in caudate, nucleus accumbens, and medial prefrontal cortex. Psychopharmacology 106, 45–52 (1992). https://doi.org/10.1007/BF02253587
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF02253587